Zacks2h agobearish
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins ExpandFMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
531last 24h
2509last 7d
478● bullish (7d)
254● bearish (7d)
197publishers
Zacks5d agobearish
SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber RecoveryStryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.
Zacks18d agobearish
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure GrowthISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements.
Simply Wall St.25d agobearish
West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its BusinessWest Pharmaceutical Services (NYSE:WST) has sold the rights and facilities related to its SmartDose 3.5 mL On Body Delivery System to AbbVie. The transaction shifts ownership of this specific large volume wearable injector platform while allowing West Pharmaceutical Services to focus on other drug delivery offerings. The deal reflects a change in how NYSE:WST is positioning its portfolio within the drug delivery and pharmaceutical packaging market. West Pharmaceutical Services operates in...
Zacks83d agobearish
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins DownDOCS' revenues top estimates as AI tool adoption and large customer growth fuel engagement despite weaker earnings and margin pressure.